Klaus Levin

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 342 citations · Full text

Medicine, Nephrology, Pharmacology +13

Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

T. Vilsbøll, Birgitte Brock, Hans Perrild et al. · Diabetic Medicine · 2008 · 213 citations

Medicine, Endocrinology, Pharmacology +17

Heritability of Insulin Secretion, Peripheral and Hepatic Insulin Action, and Intracellular Glucose Partitioning in Young and Old Danish Twins

Pernille Poulsen, Klaus Levin, Inge Petersen et al. · Diabetes · 2005 · 171 citations · Full text

Medicine, Endocrinology, Physiology +14

Identification of the Oxidized Low-Density Lipoprotein Scavenger Receptor CD36 in Plasma

Aase Handberg, Klaus Levin, Kurt Højlund et al. · Circulation · 2006 · 164 citations · Full text

Life Sciences, Biochemistry, Endocrinology +14

A Novel Syndrome of Autosomal-Dominant Hyperinsulinemic Hypoglycemia Linked to a Mutation in the Human Insulin Receptor Gene

Kurt Højlund, Torben Hansen, Maria Lajer et al. · Diabetes · 2004 · 131 citations · Full text

Medicine, Endocrinology, Genetics +17